Table 1.
Demographic, clinical, and adverse effect data of the high and low neuroticism groups at survey
| Variables | High neuroticism (N = 107) | Low neuroticism (N = 417) | p value | Total sample (N = 524) |
|---|---|---|---|---|
| Age at survey, mean (SD) | 64.8 (5.9) | 66.1 (5.9) | 0.06 | 65.8 (5.9) |
| Years RALP-survey, mean (SD) | 3.2 (1.2) | 3.3 (1.3) | 0.19 | 3.3 (1.3) |
| D’Amico risk groups, N (%) | 0.07 | |||
| Low | 37 (35) | 99 (24) | 136 (26) | |
| Intermediate | 42 (39) | 201 (48) | 243 (46) | |
| High | 28 (26) | 117 (28) | 145 (28) | |
| Positive margins, N (%) | 16 (15) | 70 (17) | 0.65 | 86 (16) |
| Nerve sparing, N (%) | 0.34 | |||
| None | 30 (28) | 91 (22) | 121 (23) | |
| Unilateral | 49 (46) | 196 (47) | 245 (47) | |
| Bilateral | 28 (26) | 130 (31) | 158 (30) | |
| Paired relationship, N (%) | 99 (93) | 381 (91) | 0.70 | 480 (92) |
| Short education, N (%) | 58 (54) | 150 (36) | < 0.001 | 209 (39) |
| Currently working, N (%) | 54 (51) | 195 (47) | 0.47 | 249 (49) |
| Comorbidity, N (%) | 0.001 | |||
| None | 33 (31) | 190 (46) | 223 (43) | |
| 1 disease | 39 (36) | 154 (37) | 193 (37) | |
| ≥ 2 diseases | 35 (33) | 73 (17) | 108 (20) | |
| EPIC-26 scores, mean (SD) | ||||
| Urinary domain* | 69.9 (24.7) | 80.2 (20.6) | < 0.001 | 78.1 (21.8) |
| Incontinence subscale | 67.8 (27.5) | 74.7 (25.6) | 0.014 | 73.3 (26.1) |
| Irritation/obstruction subscale* | 74.0 (29.7) | 85.4 (23.4) | < 0.001 | 83.1 (25.0) |
| Bowel domain* | 83.3 (22.2) | 93.5 (14.0) | < 0.001 | 91.5 (16.5) |
| Sexual domain* | 27.5 (26.2) | 36.3 (28.9) | 0.003 | 34.5 (28.6) |
| Hormonal domain* | 66.0 (23.7) | 91.7 (15.5 | < 0.001 | 86.5 (20.3) |
| EPIC-26 categories, N (%) | ||||
| Daily use of pads | 42 (40) | 142 (35) | 0.32 | 184 (36) |
| Inability to perform intercourse | 89 (83) | 302 (72) | 0.023 | 391 (75) |
*Between-groups mean score differences > 10% of total mean score [19]